We previously demonstrated that reducing Scn8a expression is therapeutic in Scn1a+/− mice (Lenk et al., 2020) and in mice with epilepsy caused by loss of the potassium channel genes Kcna1 and Kcnq2 (Hill et al., 2022). The gene discussed is KCNA3; the disease is epilepsy.